Kidney transplantation in hepatitis B virus (HBV)-infected donors and/or recipientshas become possible with the advent of antiviral therapies, but nephrologists should be aware of the potential risks of HBV flare and ensure that timely preventive measures are instituted.
Studies on the inorganic compound sodium zirconium cyclosilicate and the hypoxia inducible factor prolyl hydroxylase (HIF-PH) pathway inhibitor roxadustat have shown efficacy and safety for the management of hyperkalaemia and anaemia, respectively, among chronic kidney disease (CKD) patients.
Most immune-related toxicities resulting from lung cancer immunotherapy usually involve the skin, lungs, endocrine system and the gastrointestinal (GI) tract and are manageable with immunomodulatory agents such as corticosteroids.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
A subgroup of patients with HBeAg-negative chronic hepatitis B virus (HBV) infection who ceased their long-term nucleotide analogue treatment maintained virological suppression, pointing to a group of patients who may be suitable for treatment cessation, according to a recent study.
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.